177 related articles for article (PubMed ID: 15223650)
1. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases.
Lester R; Li C; Phillips P; Shenkier TN; Gascoyne RD; Galbraith PF; Vickars LM; Leitch HA
Leuk Lymphoma; 2004 Sep; 45(9):1881-5. PubMed ID: 15223650
[TBL] [Abstract][Full Text] [Related]
2. Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy.
Navarro JT; Ribera JM; Oriol A; Xicoy B; Mate JL; Sirera G; Lloveras N; Millá F; Feliu E
Int J Hematol; 2007 Nov; 86(4):337-42. PubMed ID: 18055341
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.
Kirk O; Pedersen C; Cozzi-Lepri A; Antunes F; Miller V; Gatell JM; Katlama C; Lazzarin A; Skinhøj P; Barton SE;
Blood; 2001 Dec; 98(12):3406-12. PubMed ID: 11719381
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
5. Impact of highly active antiretroviral therapy in the development and remission of oral plasmablastic lymphoma.
Wagner VP; Ortiz L; da Silva HP; Meurer L; da Cunha Filho JJ; Martins MA; Martins MD
Indian J Dent Res; 2016; 27(5):559-562. PubMed ID: 27966518
[TBL] [Abstract][Full Text] [Related]
6. Plasmablastic lymphoma in a previously undiagnosed AIDS patient: a case report.
Vieira FO; El Gandour O; Buadi FK; Williams GB; Shires CB; Zafar N
Head Neck Pathol; 2008 Jun; 2(2):92-6. PubMed ID: 20614329
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated oral plasmablastic lymphoma and role of adherence to highly active antiretroviral therapy.
Francischini E; Martins FM; Braz-Silva PH; Magalhães MH; Ortega KL
Int J STD AIDS; 2010 Jan; 21(1):68-70. PubMed ID: 19884361
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
Ratner L; Lee J; Tang S; Redden D; Hamzeh F; Herndier B; Scadden D; Kaplan L; Ambinder R; Levine A; Harrington W; Grochow L; Flexner C; Tan B; Straus D;
J Clin Oncol; 2001 Apr; 19(8):2171-8. PubMed ID: 11304769
[TBL] [Abstract][Full Text] [Related]
9. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
Diamond C; Taylor TH; Im T; Anton-Culver H
Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
[TBL] [Abstract][Full Text] [Related]
10. Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
Atallah-Yunes SA; Murphy D; Abdelmalak R; Mantle L; Ali SS
Eur J Haematol; 2019 Dec; 103(6):620-622. PubMed ID: 31505061
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
[TBL] [Abstract][Full Text] [Related]
12. Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.
Engels EA; Pfeiffer RM; Landgren O; Moore RD
J Acquir Immune Defic Syndr; 2010 May; 54(1):78-84. PubMed ID: 20418723
[TBL] [Abstract][Full Text] [Related]
13. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
Castillo J; Pantanowitz L; Dezube BJ
Am J Hematol; 2008 Oct; 83(10):804-9. PubMed ID: 18756521
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity.
Panos G; Karveli EA; Nikolatou O; Falagas ME
Am J Hematol; 2007 Aug; 82(8):761-5. PubMed ID: 17094093
[TBL] [Abstract][Full Text] [Related]
16. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
17. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
18. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial.
Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D
Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436
[TBL] [Abstract][Full Text] [Related]
19. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
